The truth is, while GLP-1s are powerful tools, there are several key factors that influence their effectiveness, and understanding them is crucial for your success
The clinical evidence behind the compounds A program's results rest on the compound it dispenses, not on the platform
On Oct 18, 2017, Novo Nordisk received positive 16-0 vote from FDA Advisory Committee in favor of approval for Semaglutide
Documentation : Maintain detailed records to demonstrate medical necessity
"Medicare Advantage Insurers Made Nearly 50 Million Prior Authorization Requests in 2023." American Hospital Association
If youre considering starting GLP-1 medications, its crucial to discuss this with a Bariatric Medical practitioner a doctor who is an expert in prescribing, monitoring and educating you about the appropriateness of these medications for you